sulfonylurea vs glp 1 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Mapping the effectiveness and risks
Description
This matters because beneficiaries may assume that any prescription cost they pay at the pharmacy counts toward their Part D spending
Initial Combination Therapy with Metformin A total of 1091 patients with type 2 diabetes and inadequate glycemic control on diet and exercise participated in a 24-week, randomized, double-blind, placebo-controlled factorial study designed to assess the efficacy of sitagliptin as initial therapy in combination with metformin
As such, informed consent was not required
Figure 3 summarizes the main advantages and disadvantages of GLP-1 RA prescription
Its not clear how long they will last
